PCNA-I1

CAS No. 444930-42-1

PCNA-I1( —— )

Catalog No. M24405 CAS No. 444930-42-1

PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 206 In Stock
5MG 187 In Stock
10MG 297 In Stock
25MG 493 In Stock
50MG 693 In Stock
100MG 995 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PCNA-I1
  • Note
    Research use only, not for human use.
  • Brief Description
    PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
  • Description
    PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PCNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    444930-42-1
  • Formula Weight
    310.37
  • Molecular Formula
    C17H14N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC1=C(SC=C1)C(=O)N/N=C/C2=C(C3=CC=CC=C3C=C2)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dillehay K L , Lu S , Dong Z . Antitumor Effects of a Novel Small Molecule Targeting PCNA Chromatin Association in Prostate Cancer[J]. Molecular Cancer Therapeutics, 2014, 13(12):2817-26.
molnova catalog
related products
  • 4-Aminophenyl 6-deox...

    4-Aminophenyl 6-deoxy-α-L-mannopyranoside is a glycoside that can be isolated from Camellia oleifera seeds.

  • Gefapixant citrate

    Gefapixant citrate is an orally active P2X3 receptor (P2X3R) antagonist that acts on human homologous recombinant hP2X3 (IC50: ~30 nM) and hP2X2/3 (IC50: 100-200 nM).

  • SBI-477

    SBI-477 is a chemical probe stimulated insulin signaling by deactivating the transcription factor MondoA. SBI-477 coordinately inhibits triacylglyceride (TAG) synthesis and enhances basal glucose uptake in human skeletal myocytes.